MAZE Smart Money
Maze Therapeutics, Inc.
1W: -2.3%
1M: +18.0%
3M: +16.2%
YTD: -20.3%
1Y: +4.3%
$31.69
+0.62 (+2.00%)
Pre-Market: $32.12 (+0.43, +1.37%)
Weekly Expected Move ±7.7%
$26
$29
$31
$33
$36
Credit Risk of going bust: lower than 59% of companies Debt: 3.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.10 (down 99.7%), Maze Therapeutics, Inc. would be worth roughly what it owes.
Total debt $60.4M against a stock market value of $1.76B.
Distance to default 6.15 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $19.5M (short-term plus half of long-term), stock volatility 70.9%; Altman Z'' 5.87. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.10 (down 99.7%), Maze Therapeutics, Inc. would be worth roughly what it owes.
Total debt $60.4M against a stock market value of $1.76B.
Distance to default 6.15 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $19.5M (short-term plus half of long-term), stock volatility 70.9%; Altman Z'' 5.87. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026206
Institutions Holding
+14 vs prior
94.2%
Ownership
+7.53%
41
New
65
Increased
77
Reduced
39
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Coloma Jason V | officer: chief executive officer | S-Sale | 31,908 | $27.02 | $862K | Filing |
| 2026-10-01 | Coloma Jason V | officer: chief executive officer | S-Sale | 2,593 | $27.02 | $70K | Filing |
| 2026-10-01 | Bernstein Harold | officer: president, r&d & cmo | S-Sale | 16,141 | $26.93 | $435K | Filing |
| 2026-09-29 | Dandekar Atul | officer: csbo | S-Sale | 7,500 | $27.06 | $203K | Filing |
| 2026-09-04 | Bernstein Harold | officer: president, r&d & cmo | S-Sale | 9,705 | $26.22 | $255K | Filing |
| 2026-09-03 | Dandekar Atul | officer: csbo | S-Sale | 3,207 | $26.01 | $83K | Filing |
| 2026-09-03 | Coloma Jason V | officer: chief executive officer | S-Sale | 11,282 | $26.01 | $293K | Filing |
| 2026-09-03 | Coloma Jason V | officer: chief executive officer | S-Sale | 129 | $25.77 | $3K | Filing |
| 2026-09-03 | Bernstein Harold | officer: president, r&d & cmo | S-Sale | 59 | $25.78 | $2K | Filing |
| 2026-09-03 | Bernstein Harold | officer: president, r&d & cmo | S-Sale | 5,130 | $26.01 | $133K | Filing |
| 2026-09-03 | Courtney Phillips | officer: gc and corp. secretary | S-Sale | 1,990 | $26.01 | $52K | Filing |
| 2026-09-03 | Courtney Phillips | officer: gc and corp. secretary | S-Sale | 22 | $25.78 | $567 | Filing |
| 2026-09-03 | Dandekar Atul | officer: csbo | S-Sale | 36 | $25.81 | $929 | Filing |
| 2026-09-02 | Dandekar Atul | officer: csbo | S-Sale | 391 | $27.12 | $11K | Filing |
| 2026-09-02 | Bernstein Harold | officer: president, r&d & cmo | S-Sale | 4,481 | $26.38 | $118K | Filing |
| 2026-09-02 | Bernstein Harold | officer: president, r&d & cmo | S-Sale | 625 | $27.12 | $17K | Filing |
| 2026-09-02 | Dandekar Atul | officer: csbo | S-Sale | 2,800 | $26.38 | $74K | Filing |
| 2026-09-02 | Courtney Phillips | officer: gc and corp. secretary | S-Sale | 243 | $27.12 | $7K | Filing |
| 2026-09-02 | Courtney Phillips | officer: gc and corp. secretary | S-Sale | 1,738 | $26.38 | $46K | Filing |
| 2026-09-02 | Coloma Jason V | officer: chief executive officer | S-Sale | 1,375 | $27.12 | $37K | Filing |
| 2026-09-02 | Coloma Jason V | officer: chief executive officer | S-Sale | 9,852 | $26.38 | $260K | Filing |
| 2026-09-01 | Coloma Jason V | officer: chief executive officer | S-Sale | 31,908 | $26.29 | $839K | Filing |
| 2026-09-01 | Bernstein Harold | officer: president, r&d & cmo | S-Sale | 16,141 | $26.36 | $426K | Filing |
| 2026-09-01 | Coloma Jason V | officer: chief executive officer | S-Sale | 2,593 | $26.31 | $68K | Filing |
| 2026-08-28 | Dandekar Atul | officer: csbo | S-Sale | 7,500 | $27.58 | $207K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 5,032,915 | $150M | +465,641 | 2026-06-30 | Filing |
| TRV GP IV, LLC | 4,473,958 | $134M | — | 2026-06-30 | Filing |
| ARCH Venture Management, LLC | 4,120,053 | $123M | — | 2026-06-30 | Filing |
| Deep Track Capital, LP | 3,732,569 | $111M | +255,007 | 2026-06-30 | Filing |
| BlackRock, Inc. | 3,502,841 | $105M | +932,416 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 3,408,045 | $102M | +3,408,045 | 2026-06-30 | Filing |
| Logos Global Management LP | 1,935,000 | $58M | +700,000 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,778,222 | $53M | +342,566 | 2026-06-30 | Filing |
| a16z Capital Management, L.L.C. | 1,702,225 | $51M | — | 2026-06-30 | Filing |
| Venrock Adviser, LLC | 1,602,034 | $48M | — | 2026-06-30 | Filing |
| Alphabet Inc. | 1,388,583 | $41M | — | 2026-06-30 | Filing |
| BRAIDWELL LP | 1,140,040 | $34M | +1,140,040 | 2026-06-30 | Filing |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1,107,814 | $33M | +734,814 | 2026-06-30 | Filing |
| FMR LLC | 1,056,959 | $32M | +192,745 | 2026-06-30 | Filing |
| General Catalyst Group Management, LLC | 1,035,910 | $31M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 997,533 | $30M | +360,811 | 2026-06-30 | Filing |
| Driehaus Capital Management LLC | 954,886 | $28M | +318,724 | 2026-06-30 | Filing |
| TRV GP V, LLC | 950,800 | $28M | — | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 964,011 | $28M | +905,565 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 914,572 | $27M | +603,933 | 2026-06-30 | Filing |